Gasolense-D Tablet is a combination medication containing Domperidone 10 mg and Pantoprazole 40 mg, indicated for the management of gastrointestinal disorders characterized by symptoms such as acid reflux, heartburn, nausea, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms of nausea and vomiting. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related disorders including gastroesophageal reflux disease (GERD) and erosive esophagitis. The synergistic action of these two agents addresses both the motility and acid secretion components of upper gastrointestinal conditions, enhancing symptomatic relief and promoting mucosal healing. Gasolense-D is typically prescribed for short-term use under medical supervision, with dosing tailored according to the severity of symptoms and patient response. It is contraindicated in patients with known hypersensitivity to either component and should be used cautiously in individuals with underlying cardiac conditions due to the potential risk of QT prolongation associated with Domperidone. Common adverse effects may include headache, dry mouth, and abdominal discomfort. Consultation with a healthcare professional is essential prior to initiating therapy to ensure appropriate use and monitoring.